Package Leaflet: Information for the User
Levodopa/Carbidopa/Entacapone Kern Pharma 150 mg/37.5 mg/200 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
5 Conservation of Levodopa/Carbidopa/Entacapone Kern Pharma
This medicine contains three active substances (levodopa, carbidopa, and entacapone) in one film-coated tablet. Levodopa/Carbidopa/Entacapone Kern Pharma is used to treat Parkinson's disease.
Parkinson's disease is due to a low concentration in the brain of a substance called dopamine. Levodopa increases the amount of dopamine and, in this way, reduces the symptoms of Parkinson's disease. Carbidopa and entacapone improve the antiparkinsonian effects of levodopa.
Do not take Levodopa/Carbidopa/Entacapone Kern Pharma if
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine if you suffer or have ever suffered from:
Consult your doctor if you are taking:
Consult your doctor if, during treatment with this medicine, you:
Tell your doctor if you or your family/caregiver notice that you are developing desires or tendencies to behave in an unusual way for you or that you cannot resist the impulse, determination, or temptation to perform certain activities that may harm you or others. These behaviors are called impulse control disorders and may include addiction to gambling, food, or excessive spending, and an abnormally high sexual impulse or concern with an increase in sexual thoughts or feelings. Your doctor may need to review your treatment.
Tell your doctor if you, or your family/caregiver, notice that you are developing symptoms similar to addiction, leading to a desire for large doses of Levodopa/Carbidopa/Entacapone Kern Pharma and other medicines used to treat Parkinson's disease.
During prolonged treatment with Levodopa/Carbidopa/Entacapone, your doctor may perform regular blood tests.
If you need to undergo surgery, you should inform your doctor that you are taking this medicine.
It is not recommended to use Levodopa/Carbidopa/Entacapone for the treatment of extrapyramidal symptoms (e.g., involuntary movements, agitation, muscle stiffness, and muscle contractions) caused by other medicines.
Children and adolescents
Experience with the use of Levodopa/Carbidopa/Entacapone in patients under 18 years of age is limited. Therefore, its administration is not recommended in children.
Taking Levodopa/Carbidopa/Entacapone Kern Pharma with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Do not take this medicine if you are taking certain medicines for depression (combinations of selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).
Levodopa/Carbidopa/Entacapone may increase the effect and also the side effects of certain medicines. These include:
Certain medicines may reduce the effects of Levodopa/Carbidopa/Entacapone. These medicines are:
Levodopa/Carbidopa/Entacapone may hinder the absorption of iron at the digestive level. Therefore, you should not take Levodopa/Carbidopa/Entacapone at the same time as taking iron supplements. If you take any of them, you should wait at least 2 or 3 hours before taking the other.
Taking Levodopa/Carbidopa/Entacapone Kern Pharma with food and drinks
This medicine can be taken with or without food.
It may be that in some patients, Levodopa/Carbidopa/Entacapone is not well absorbed if taken with foods rich in protein (meat, fish, dairy products, cereals, and nuts) or shortly after consuming them.
Consult your doctor if you think this is happening in your case.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not breastfeed while taking this medicine.
Driving and using machines
Levodopa/Carbidopa/Entacapone may reduce your blood pressure, which can cause dizziness or fainting. Therefore, be especially careful when handling tools or machinery.
If you feel very tired or notice that you have fallen asleep suddenly, wait until you feel fully awake again before driving or doing anything that requires you to be alert. Otherwise, you may put yourself and others at risk of a serious or even fatal accident.
Levodopa/Carbidopa/Entacapone Kern Pharma 150 mg/37.5 mg/200 mg contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Levodopa/Carbidopa/Entacapone Kern Pharma 150 mg/37.5 mg/200 mg contains carmoisine (E-122)
This medicine may cause allergic reactions because it contains carmoisine (E-122). It can cause asthma, especially in patients allergic to acetylsalicylic acid.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Adults and elderly:
Talk to your doctor or pharmacist if you think the effect of this medicine is too strong or too weak, or if you suffer from possible side effects.
If you take more Levodopa/Carbidopa/Entacapone Kern Pharma than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 915 620 420, indicating the medicine and the amount ingested.
You may feel dizzy or agitated, your heart rate may be slower or faster than normal, or your skin, tongue, eyes, or urine may change color.
If you forget to take Levodopa/Carbidopa/Entacapone Kern Pharma
Do not take a double dose to make up for forgotten doses.
If it is more than 1 hour until the next dose:
Take a tablet as soon as you remember, and the next one at the usual time.
If it is less than 1 hour until the next dose:
Take a tablet as soon as you remember, wait 1 hour, and take another tablet then. Then, continue as usual.
There should always be 1 hour between tablets of this medicine to avoid possible side effects.
If you stop taking Levodopa/Carbidopa/Entacapone Kern Pharma
Do not stop taking this medicine unless your doctor tells you to. In that case, your doctor may need to adjust the dose of your other Parkinson's medicines, especially levodopa, to ensure sufficient control of your symptoms. If you stop taking Levodopa/Carbidopa/Entacapone and other Parkinson's medicines abruptly, you may suffer from unwanted side effects.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Many can be alleviated by adjusting the dose.
If you experience any of these symptoms during treatment with this medicine, contact your doctor immediately:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
The following side effects have also been reported:
You may experience the following side effects:
Inability to resist the impulse to perform an action that could be harmful, and that could include:
Tell your doctor if you experience any of these behaviors; they will discuss how to manage or reduce these symptoms.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects that are not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: www.notificaram.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Discard the product 175 days after opening the packaging.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Levodopa/Carbidopa/EntacaponeKern Pharma
The active ingredients are levodopa, carbidopa, and entacapone. Each coated tablet contains 150 mg of levodopa, 37.5 mg of carbidopa, and 200 mg of entacapone.
The other components are: microcrystalline cellulose, anhydrous lactose, hydroxypropylcellulose, povidone (E-1201), colloidal anhydrous silica, magnesium stearate, titanium dioxide (E-171), hypromellose, glycerol (E-422), polysorbate 80, red iron oxide (E-172), and carmoisine (E-122).
Product Appearance and Package Contents
Oval, biconvex tablets, dark red in color, engraved with "150" on one side, smooth on the other.
Levodopa/Carbidopa/Entacapone Kern Pharma 150 mg/37.5 mg/200 mg is available in packages of 100 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
Manufacturer:
Teva Pharmaceutical Works Private
Pallagi út 13, 4042 Debrecen
Hungary
or
Teva UK Limited
Brampton Road, Hampden Park,
Eastbourne, East Sussex, BN22 9AG,
United Kingdom
Date of the Last Revision of this Leaflet: September 2019.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 150 mg / 37.5 mg / 200 mg FILM-COATED TABLETS in October, 2025 is around 78.48 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.